Show Filters

Searches all publications.

Search Fulltext



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-11-18
    E.g., 2018-11-18


12389 items
3:52 PM, Oct 25, 2018  |  BC Extra | Financial News

89Bio, a NASH start-up with Teva ties, debuts with $60M

89Bio Ltd. (San Francisco, Calif.) will use its $60 million series A financing to develop therapeutics for non-alcoholic steatohepatitis and other liver and metabolic diseases. The financing was co-led by OrbiMed Israel, OrbiMed US and...
6:27 AM, Oct 25, 2018  |  BC Extra | Financial News

Milestone raises $80M to fund pivotal trial of at-home tachycardia therapy

Milestone Pharmaceuticals Inc. (Montreal, Quebec) raised $80 million in a series D to support a Phase III trial of its self-administered acute paroxysmal supraventricular tachycardia (PSVT) treatment, etripamil. Milestone began a Phase III study of...
4:32 PM, Oct 24, 2018  |  BC Extra | Financial News

NBI drops 6% and into the red for 2018

The NASDAQ Biotechnology Index experienced its worst day in more than seven years on Wednesday as biotech losses outpaced the broader market. Stocks across the board were dragged down by technology stocks and multiple other...
2:05 PM, Oct 24, 2018  |  BC Extra | Financial News

Innovent raises $421M in Hong Kong IPO

Cancer and autoimmune company Innovent Biologics Inc. (HKSE:1801) priced its IPO on the Hong Kong stock exchange, raising HK$3.3 billion ($421 million), according to a source close to the deal who asked not to be...
11:23 AM, Oct 23, 2018  |  BC Extra | Financial News

First close for China Everbright’s new healthcare fund

China Everbright Ltd. (HKSE:165) completed the first close of its third healthcare fund, raising more than RMB800 million ($115.4 million). The CEL Healthcare Fund III's target size is RMB1.5 billion ($216.3 million). According to China Everbright,...
4:01 AM, Oct 23, 2018  |  BC Extra | Financial News

Synthego raises $110M series C to scale up CRISPR research products

Synthego Corp. (Redwood City, Calif.) raised a $110 million series C round to grow its CRISPR-based product line for researchers. Founders Fund led the round, which was also backed by fellow existing investors 8VC and...
3:00 AM, Oct 23, 2018  |  BC Extra | Financial News

Stoke prepares for IND, IPO with $90M series B

Stoke Therapeutics Inc. (Bedford, Mass.) is eyeing an IPO next half after raising $90 million in a series B round from a slew of new investors. The company's Targeted Augmentation of Nuclear Gene Output (TANGO)...
5:02 AM, Oct 22, 2018  |  BC Extra | Financial News

Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal

With $33 million in new series A funding, a portfolio of preclinical assets from The Medicines Co. (NASDAQ:MDCO) and a BARDA deal, Qpex Biopharma Inc. (San Diego, Calif.) hopes to begin clinical studies of multiple...
12:25 PM, Oct 19, 2018  |  BC Extra | Financial News

LogicBio marks week’s third IPO to miss price target

LogicBio Therapeutics Inc. (NASDAQ:LOGC) priced its IPO below its proposed range late Thursday, joining two other biotechs that missed their target price this week. But shares of the genome editing company jumped $1.90 (19%) to...
5:26 AM, Oct 19, 2018  |  BC Extra | Financial News

Ahead of Phase II, TP raises $80M mezzanine round

Oncology company TP Therapeutics Inc. (San Diego, Calif.) raised $80 million in a mezzanine round and promoted Athena Countouriotis to CEO from CMO as the company readies to begin a potentially registrational Phase II study...